Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Vehicle-controlled, Randomized Study to Evaluate the Safety, Tolerability, Systemic Pharmacokinetics, and Pharmacodynamics of AZR-MD-001 in Patients With Meibomian Gland Dysfunction (MGD) and Evaporative Dry Eye Disease (DED)

NCT03652051 is registered in ClinicalTrials.gov with Azura Ophthalmics as lead sponsor.

NCT NCT03652051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03652051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Vehicle-controlled, Randomized Study to Evaluate the Safety, Tolerability, Systemic Pharmacokinetics, and Pharmacodynamics of AZR-MD-001 in Patients With Meibomian Gland Dysfunction (MGD) and Evaporative Dry Eye Disease (DED)
Lead sponsor
Azura Ophthalmics
Phase
Phase 2
Overall status
Completed
Start date
September 10, 2018
Completion date
October 19, 2022
Enrollment
321 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye, meibomian gland dysfunction